Concord Drugs Ltd — Insider Trade, 26-06-2025: Insider Trading / SAST

Concord Drugs Limited has announced a closure of its trading window starting from 1st July, 2025 until 48 hours after the announcement of the financial results for the quarter ending June 2025. During this period, all directors, designated employees, insiders, and their immediate relatives are restricted from trading the company’s securities. This step aims to prevent insider trading ahead of the quarterly financial disclosure, ensuring fair market practices and transparency for shareholders.